Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia
NCT ID: NCT06939634
Last Updated: 2025-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2024-06-01
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Safety and Performance of the Atalante System With Patients With Lower Limb Paralysis
NCT04110561
Effect of the Atalante Exoskeleton on Standing and Walking in Individuals With Paraplegia: A Prospective Controlled-Environment Study in a Rehabilitation Context
NCT06941896
Lower-Limb Exoskeleton Technology for Non-Ambulatory Individuals With Spinal Cord Injury
NCT07128901
Assessment of the Interest of the Atalante Device for Patients With Manual Wheelchairs
NCT05909774
Human Factors Validation Testing of the Wandercraft Personal Exoskeleton
NCT06715631
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hands-free exoskeleton
Patient with high paraplegia or tetraplegia who have undergone at least one session with the exoskeleton.
Hands-free exoskeleton
Having undergone at least on session with Atalante exoskeleton. Clinical, safety and session data are collected retrospectively.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hands-free exoskeleton
Having undergone at least on session with Atalante exoskeleton. Clinical, safety and session data are collected retrospectively.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tetraplegia or high paraplegia (at or above T4) regardless of the cause,
* Non-opposition to the participation to the study,
* Having undergone a minimum of 1 session with the Atalante device from February 2019, to now.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wandercraft
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation Hopale
Berck, France, France
CMPR de Pionsat
Pionsat, France, France
Hôpital La Musse
Saint-Sébastien-de-Morsent, France, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIP009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.